Noble Financial
http://www.nobleresearch.com/index.htmNoble Financial is a capital markets firm. The firm provides private client services, equity research, sales and trading services, and investment banking services. The sectors in Noble’s coverage universe include healthcare services, media/entertainment, biotechnology, consumer, software, and business services.
View Older Stories View More Recent Stories
-
Kratos Defense's (KTOS) UTAP-22 Development Expenses Should Notably Drop in 2016 - Noble Financial
-
Naked Brand Group, Inc. (NAKD) Prices 1.875M Common Offering at $4/Share
-
Naked Announces Pricing of Underwritten Public Offering for 1,875,000 Shares of Common Stock and NASDAQ Uplisting
-
Five Panels and Workshops Added to Noble Financial's Investor Conference; January in South Florida
-
Streetinsider.com's Hot Lunchtime Reads 12/15: (FB) (INFN) (VRX) (WRES)
-
Noble Financial Cuts Warren Resources (WRES) to Hold Following Recent Weakness
-
Noble Financial Keeps Peregrine Pharma (PPHM) at 'Buy' Amid Expansion of Bavituximab Immunooncology Programs
-
Streetinsider.com's Hot Lunchtime Reads 12/10: (KBIO) (YHOO) (OPXA) (DD)
-
Noble Financial Affirms Comtech (CMTL) at 'Buy' Following Light Q1 Results, Reaffirmed Guidance
-
Noble, FAU and MobileHelp(TM) Partner to Bring Top Students to Noble Financial's NobleCon12
-
Implant Sciences to Explore Strategic Options as Growing Security Needs for Soft Targets Drives Spending on Security Technologies
-
PetroShare Corp. Closes $4.6 Million Public Offering; Approved for Trading on OTCQB
-
Amtech Systems' (ASYS) Financial Position Remains Solid, But Operations are Still Weak - Noble Financial
-
Noble Financial Upgrades 1-800-FLOWERS.COM (FLWS) to Buy
-
Noble Financial Starts Coeur d'Alene Mines (CDE) at Hold
-
Noble Financial Downgrades CACI International (CACI) to Hold
-
Townsquare Media (TSQ) Valuation Remains Following Q3 Beat; Noble Financial Affirms at 'Buy'
-
TxCell: Financial Information for the 3rd quarter of 2015
-
Streetinsider.com's Hot Lunchtime Reads 10/28: (KING) (POM) (PYPL) (MRCY)
-
Noble Financial Maintains Mercury Computer Systems (MRCY) at 'Hold'; Current Valuation Seen as Fair
-
Enterprise Florida to Partner With Noble Financial Capital Markets to Increase Florida Company Participation at NobleCon12
-
ContraVir Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock And Warrants
-
Streetinsider.com's Hot Lunchtime Reads 10/13: (TSLA) (TXMD) (FIG) (ACI)
-
Noble Financial Maintains 'Buy' Rating on TherapeuticsMD (TXMD) Following Completion of REPLENISH Enrollment
-
Streetinsider.com's Hot Lunchtime Reads 10/12: (TWOU) (FB) (BCRX) (NVDA)
-
Noble Financial Affirms BioCryst Pharma (BCRX) at 'Buy' Following BCX7353 Phase 1 Update
-
Notable Analyst Rating Changes 10/7: (CTRP) (MS) (ABT) Upgraded; (TSLA) (PSX) (BIDU) Downgraded
-
Noble Financial Starts Evoke Pharma (EVOK) at Buy
-
ContraVir Pharma (CTRV) Prices Offering of Common Stock and Warrants
-
ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock
-
TxCell to present its cellular immunotherapy developments at leading investor conferences
-
Noble Financial Starts Pershing Gold (PGLC) at Buy
-
Recent Insider Purchases at Kratos (KTOS) Highlight Value - Noble Financial
-
Noble Financial Adjusts Ests on 1-800-FLOWERS (FLWS) Following Q4 Report; Revenue Tracting Still Needs to Take Hold
-
Noble Financial Downgrades Gastar Exploration Limited (GST) to Hold
-
Noble Financial Bumps PT on Palatin Technologies (PTN) to $4 Following Flibanserin for HSDD Approval
-
Naked Receives $2.34 Million in Proceeds from Warrant Exercise Offer
-
Noble Financial Trims NAV on Miller Energy (MILL) Following Q2 Results; Maintains 'Hold' Rating
-
Approval of Novartis' (NVS) Entresto is Positive for Palatin (PTN); Noble Affirms at 'Buy'
-
Noble Financial Boosts PT on Heron Therapeutics (HRTX) to $41 Following SUSTOL NDA Resubmission
-
Notable Analyst Rating Changes 7/17: (BAC) (ENDP) (WCN) Upgraded; (BBY) (TNGO) (DPZ) Downgraded
-
Noble Financial Starts McClatchy (MNI) at Buy
-
UPDATE: Noble Financial Starts Peregrine Pharmaceuticals (PPHM) at Buy; Positive on Phosphatidylserine Potential
-
Noble Financial Cuts PT on Harte-Hanks (HHS) to $9 Following Surprise CEO Resignation
-
Modest Growth Outlook for CACI Int'l (CACI) in FY16 is Still Growth - Noble Financial
-
NobleCon12 Set for Club Med South Florida, January 2016
-
Noble Life Science Partners and JSB Partners Forge Strategic Relationship
-
TherapeuticsMD's (TXMD) ACOG Meeting Presentation Encouraging; Noble Financial Affirms 'Buy' Rating
-
Noble Financial Starts VBI Vaccines (VBIV) at Buy, PT $7
-
Noble Financial Downgrades iGATE (IGTE) to Hold; Another Bidder May Enter Fray

